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A B S T R A C T
Objectives: Multidrug-resistant (MDR) Klebsiella pneumoniae is increasing worldwide with poorly
characterised epidemiology in many parts of the world, particularly in Africa. This study aimed to
investigate the molecular epidemiology of K. pneumoniae, to identify the diversity of sequence types (ST),
and to detect carbapenem resistance genes in major regional hospitals in Khartoum, Sudan.
Methods: Klebsiella pneumoniae isolates (n = 117) were cultured from four hospitals in Khartoum, from
April 2015 to October 2016. The isolates were characterised by sequencing of 16S-23S rDNA internal
transcribed spacer (ITS) region. Molecular epidemiology was determined by multilocus sequence typing
(MLST), and analysed by maximum likelihood phylogeny (PhyML). Antimicrobial susceptibility was
determined by disk diffusion. Isolates phenotypically resistant to carbapenem were screened for
carbapenemase genes: blaNDM, blaOXA48, blaIMP, blaVIM and blaGES by PCR.
Results: ITS sequencing confirmed the 117 isolates as K. pneumoniae. MLST revealed 52 different STs
grouped in four distinct clusters by PhyML. All isolates were MDR, and carbapenemase-producing K.
pneumoniae (CP-KP) isolates accounted for 44/117 (37.6%) mostly harbouring blaNDM (28/44) and blaOXA-
48 (7/44), with several isolates harbouring multiple genes.
Conclusion: MDR and CP-KP K. pneumoniae is widespread in Khartoum hospitals, with a diverse
population of 52 STs clustering in four major lineages. There is an urgent need for systematic
epidemiological studies of drug-resistant infections across all healthcare institutions in Sudan to inform
local infection prevention and control strategies.
© 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial
Chemotherapy. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
1. Introduction
The incidence of multidrug-resistant (MDR) and carbapene-
mase-producing Klebsiella pneumoniae (CP-KP) infections has
increased during the last decade throughout the world, assigning
K. pneumoniae as one of the global priority pathogens by the World
Health Organization (WHO) [1,2] with great medical significance
implicated in urinary tract infections, pneumonia, bacteraemia,
meningitis, and abscesses [3]. Therefore, MDR K. pneumoniae is
considered a significant health problem associated with significant
morbidity and mortality because of limited antibiotic treatment
options [4]. Carbapenems are usually the last-resort antibiotic by
virtue of their broad spectrum of activity; however, CP-KP has
created significant clinical challenges for clinicians globally,
resulting in ineffective treatments and high rates of clinical failure.
Furthermore, this problem is aggravated by the localisation of
resistance genes on mobile elements facilitating gene transfer to
susceptible isolates [5].
The burden of MDR is underestimated in many low- and
middle-income countries (LMICs), because of limitations in
diagnostic facilities [6]. In Sudan, epidemiology of MDR and CP-
KP is not well described despite being a major public health threat,
with fragmented data on the prevalence and distribution [7–9].
Quantification of CP-KP in healthcare facilities and understanding
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E.A. Osman, N.E. El-Amin, L.L. Al-Hassan et al. Journal of Global Antimicrobial Resistance 24 (2021) 241–245We have previously reported a high rate of misidentification of
. pneumoniae across Khartoum hospitals [10]. In this study, we
imed to characterise the local epidemiology by multilocus
equence typing (MLST), and the prevalence of carbapenemase
enes among K. pneumoniae isolates across Khartoum State
ospitals, thereby determining the level of inter/intra-hospital
ransmission.
. Material and methods
.1. Bacterial isolates and antimicrobial susceptibility testing
A total of 117 isolates of K. pneumoniae from patient samples
ere cultured in clinical microbiology laboratories (CML) of four
ajor teaching hospitals in Khartoum: Ribat National Hospital
RNH), Omdurman Teaching Hospital (OTH), Soba University
ospital (SUH), and Khartoum Bahri Teaching Hospital (KBTH)
etween April 2015 and October 2016. CML identify clinical
pecimens to the genus levels by conventional phenotypic and
iochemical methods. No specific selection criteria were imple-
ented, as the study aimed to collect and characterise all K.
neumoniae isolates identified in the hospitals’ CML. All acquired
solates were then confirmed genotypically by amplification of
6S-23S rDNA internal transcribed spacer (ITS) of K. pneumoniae as
escribed by our preceding study [11]. All primer sequences and
xpected amplicon sizes are listed in Table S1. Clinical data
ssociated with the isolates were collected which include age,
ender, location of patient, type of culture, and antibiotic therapy
efore and during the infection.
Susceptibility tests were done by disk diffusion for the following
0 antibiotics: amoxicillin/ampicillin (AMC/AMP) (30 mg); piper-
cillin-tazobactam (TZP) (110 mg); cefoxitin (FOX) (30 mg);
iprofloxacin (CIP) (5 mg); gentamicin (CEN) (10 mg); amikacin
AK) (30 mg); trimethoprim-sulfamethoxazole (SXT) (30 mg);
eropenem (MEM) (10mg); imipenem (IMP) (10mg). The procedure
was performed and results interpreted according to Clinical and
Laboratory Standards Institute (CLSI) guidelines [12].
2.2. Molecular typing of K. pneumoniae isolates
MLST was done to identify the STs of all the K. pneumoniae
isolates by amplification and sequencing of the seven housekeep-
ing genes [13]. The results of sequences were analysed in the
PubMLST database (https://bigsdb.pasteur.fr/klebsiella/klebsiella.
html) and BLAST (https://blast.ncbi.nlm.nih.gov/), then assigned
an allele number. The allele numbers were combined to yield a
specific ST.
A concatenated alignment with maximum likelihood phyloge-
ny (PhyML) was constructed using Seaview to determine related-
ness of isolates [14], and the PhyML was analysed with metadata
using Phandango [15].
2.3. Molecular detection of carbapenemase genes
All isolates phenotypically resistant to carbapenems were
screened for the presence of carbapenemase genes: blaNDM, and
blaIMP, blaVIM, blaKPC, blaOXA48, and blaGES by multiplex-PCR using
specific primers listed in Table S1 [16,17]. PCR reaction conditions
were prepared using ready master mix (APSLABS, India), 0.5 mL of
each primer (25 nmol concentration), and 1 mL of template DNA
(10 ng) in a total volume of 25 mL. PCR thermal profile for NDM
comprised initial denaturation at 94 C for 10 min followed by 30
cycles of 1 min at 94 C,1 min at 60 C and 1 min at 72 C, and a final
extension step of 10 min at 72 C. The PCR amplification for
multiplex (VIM, IMP and KPC) was carried out as follows: 94 C for
10 min; 30 cycles of 94 C for 40 s, 55 C for 40 s and 72 C for 1 min;
and 72 C for 7 min. The same conditions were used for multiplex
GES and OXA-48 PCR, but with an annealing temperature at 57 C
instead of 55 C. The PCR products were analysed by gel
electrophoresis.
able 1
istribution pattern of Klebsiella pneumoniae and carbapenemase-producing K. pneumoniae by age group, gender, and source of specimens.
Variables K. pneumoniae (n = 117) CP-KP (n = 44)
N (%) N (%)
Age, y
<1 28 (23.9) 9 (32.1)
1–15 21 (17.9) 9 (42.9)
16–30 17 (14.5) 8 (47.1)
31–45 16 (13.7) 6 (37.5)
46–60 19 (16.3) 6 (31.6)
>61 16 (13.7) 6 (37.5)
Gender
Male 44 (37.6) 16 (36.4)
Female 73 (62.4) 28 (38.4)
Hospitals
Ribat National Hospital (RNH) 41 (35.0) 16 (36.4)
Omdurman Teaching Hospital (OTH) 34 (29.1) 13 (29.5)
Soba University Hospital (SUH) 27 (23.1) 8 (18.2)
Khartoum Bahri Teaching Hospital (KBTH) 15 (12.8) 7 (15.9)
Hospital status
Inpatient 103 (88.0) 36 (81.8)
Outpatient 14 (12.0) 8 (18.2)
Source of specimens
Blood 28 (23.9) 8 (18.2)
Urine 27 (23.1) 13 (29.5)
Wound swab 27 (23.1) 13 (29.5)
Umbilical swab 11 (9.4) 5(11.4)
Sputum 9 (7.7) 1 (2.3)
Pus 8 (6.83) 1 (2.3)
Nasal swab 4 (3.42) 3 (6.8)
CSF 2 (1.7 0 (0)
Eye swab 1 (0.85) 0 (0)
SF = cerebrospinal fluid.
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A total of 117 MDR K. pneumoniae isolates were cultured from
different clinical samples collected from in- and outpatients across
four hospitals in Khartoum, Sudan. Table 1 summarises the
distribution pattern of K. pneumoniae by age group, gender,
hospital, and source of specimens. The highest number of K.
pneumoniae isolates was from Ribat National Hospital (RNH; n =
41; 35.0%), followed by Omdurman Teaching Hospital (OTH; n = 34;
29.1%), Soba University Hospital (SUH; n = 27; 23.1%), and
Khartoum Bahri Teaching Hospital (KBTH; n = 15; 12.8%). Isolates
were obtained from patients with a range of ages; however, the
largest number of isolates were from infants (<1 year, 23.9%). More
than 80% of isolates were from inpatients, from a variety of
samples, but more commonly blood and urine samples or wound
swabs (70.1% collectively).
As listed in Table 2, all isolates were MDR, with particularly high
resistance rates (>50%) to amoxicillin/ampicillin, piperacillin/
tazobactam, ciprofloxacin, and gentamicin. The majority of isolates
were sensitive (>60%) to amikacin and trimethoprim/sulfameth-
oxazole. Carbapenem resistance was observed in 50 isolates
(42.8%), with total resistance at 13.7% and 29.1% for imipenem and
meropenem, respectively. Antibiotic use prior to the first positive
culture was common (61.4%) in patients with a carbapenem-
resistant K. pneumoniae; only 17/44 (38.6%) had no antibiotic
therapy in the preceding 14 days (Table S2).
MLST revealed 52 different STs, 15 of which are novel and
assigned to ST3460-3474. STs 101, 383, and 649 were present in
different hospitals in Khartoum as seen in Table 3. The STs of the 44
CP-KP revealed that recurrent STs were ST 383 (n = 8, in SUH, RNH,
OTH), followed by ST 101 (n = 5, in OTH, KBTH, RNH), ST 48 (n = 3 in
KBTH), 649 (n = 3, SUH, RNH), ST 846 (n = 3, RNH) and ST 3229 (n =
2, KBTH). All other STs were identified in individual isolates
(Table 3).
As seen in Fig. 1, there is a large diversity of STs among the
isolates, with several lineages present. Results indicate that despite
distinct STs present in each hospital, with only a few recurrent STs
listed above, all STs fall into four main clusters that are present
across hospitals. Notably, ST2461 and ST2674 are highly similar
(part of cluster 2 in Fig. 1); however, isolates come from RNH and
SUH, indicating inter-hospital spread. Cluster 4 appears to contain
the largest diversity, with three sub-clusters across the four
hospitals of isolates that are both CP-KP and non-CP-KP. Some
hospitals appear to have clonally related strains, such as in OTH:
ST-654, -1289, -657, -2870, -219, -2260, -524, -2461, -2674,
belonging to cluster 2 (Fig. 1). On the other hand, SUH appears
to have a pool of diverse CP-KP and non-CP-KP. Notably, the novel
STs 3460–3474 are all carbapenem-sensitive with the exception of
ST 3467.
All isolates exhibiting phenotypic resistance to carbapenems
were screened for acquired carbapenemases as outlined in the
Methods. Forty-four isolates (37.6% of the total 117 isolates)
harboured NDM (n = 32), OXA-48 (n = 10), GES (n = 6), and VIM (3),
of which several isolates co-harboured several genes: two with
NDM and VIM, two with OXA-48 and GES, one NDM and GES, and
one with NDM, VIM, and OXA-48 (Fig. S4). NDM is present across a
range of STs in multiple hospitals.
4. Discussion
Khartoum city is the capital of Sudan and includes three
localities: Khartoum, Bahri, and Omdurman. Hospitals in the three
localities are under the umbrella of Khartoum State Ministry of
Health and they provide service to the residence of the State as well
as those who are referred from other states. This study aimed to
characterise the molecular epidemiology of a total of 117 MDR K.
pneumoniae across four major teaching hospitals that serve the
majority of the residence of the city: RNH and SUH are located in
Khartoum locality, OTH in Omdurman locality, and KBTH located in
Bahri locality. The majority of isolates were from RNH, and as
detailed in Table 1, the isolates were most commonly from infants
(<1 year old). Carbapenem resistance was unexpectedly high
(>40%), while >60% of isolates were sensitive to amikacin. Our data
(Table S2) revealed that antibiotic usage (14 days before and during
hospital admission) was a risk factor for CP-KP, mostly in patients
taking combined antibiotic therapy.
During the 19-month surveillance period 37.6% (n = 44/117) of K.
pneumoniae isolates harboured a carbapenemase, namely NDM,
VIM, OXA-48, and GES. Patients who were colonised or infected
with CP-KP had high rates of certain comorbidities including renal
disease, diabetic wounds, and solid malignancy (data not shown).
Notably, the majority of CP-KP isolates were isolated from urine
and wound, followed by blood, sputum and pus samples (Table 1),
similar to the results of other studies in Sudan, Uganda, and Nigeria
[18–20].
The emergence of CP-KP limits the use of carbapenems in
patients with severe infections, leading to increased mortality
rates. In the last decade, infections caused by carbapenem-
resistant K. pneumoniae increased significantly in many countries
in the region (Africa and the Middle East) [18,21–26]. Currently in
Sudan, carbapenems are the only available choice for the treatment
of MDR K. pneumoniae and other ESBL and AmpC-producing Gram-
negatives. However, in most cases, antibiotic prescription of
carbapenems is not based on AST, but rather based on previous
treatment failures or to be used as prophylaxis. There is therefore
an urgent need to address improving CML diagnostics, which in
turn would have a direct impact on limiting the misuse of
antibiotics, particularly carbapenems. It is important to note that
the limited diagnostic capacities in CML across hospitals in
Khartoum has led to frequent outsourcing of cultures and general
laboratory diagnostics where patients are in many instances
directed to private laboratories. Subsequently, the local data on
epidemiology and resistance are fragmented.
In this study, the prevalence of MDR was 51.2% among the K.
pneumoniae isolates, with >40% of isolates being carbapenem-
resistant. Our results indicate that isolates remain >60% sensitive
to amikacin and trimethoprim-sulfamethaxazole (SXT); however,
gentamicin resistance reached 64%. Most antibiotics in Sudan are
obtainable over the counter, which may have contributed to the
Table 2
Antimicrobial susceptibility profiles of K. pneumoniae.







AMC/AMP 2 (1.7%) 0 (0%) 115 (98.3%)
TZP 7 (5.9%) 0 (0%) 110 (94.0%)
Cefoxitin 7 (5.9%) 74 (63.2%) 36 (30.8%)
Ciprofloxacin 45 (38.5%) 12 (10.3% 60 (51.3%)
Impenem 89 (76.1%) 12 (10.3%) 16 (13.7%)
Meropenem 79 (67.5%) 4 (3.4%) 34 (29.1%)
Gentamicin 41 (35.0%) 1 (0.85%) 75 (64.1%)
Amikacin 78 (66.5%) 2 (1.7%) 37 (31.6%)
SXT 79 (67.5%) 1 (0.85%) 37 (31.6%)
AMC/AMP = amoxicillin/ampicillin; SXT = trimethoprim-sulfamethoxazole; TZP =
piperacillin-tazobactam.
243high MDR rates noted in the study. Antibiotic usage in the
community and its role in the transmission of resistance is an
important issue to study in the future.
As seen in Table 1, CP-KP was isolated from 36/44 (81.8%)
inpatients, and 8/44 (18.2%) outpatients, indicating the possible
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iversity of STs and lineages, suggesting the successful dissemina-
ion and maintenance among diverse strains.
The molecular epidemiological characterisation of K. pneumo-
iae in Khartoum, Sudan revealed a high diversity of 52 different
Ts, including 15 novel STs. However, the PhyML analysis revealed
hat despite this diversity in STs, they fall within four main clusters
irculating in different hospitals. The largest diversity of STs was
from diverse geographical settings, as these hospitals are tertiary
hospitals serving most of the country.
Successful global clones ST-383 and -101 were identified in our
study and are present in multiple hospitals indicating the
introduction and maintenance of international clones in Sudanese
hospitals, thereby confirming the role of travel and immigration in
transmission of resistance worldwide [27,28]. It is also important
to note that despite the global spread of ST-258-KPC-producer, in
able 3




24 1 CP-KP NDM 1 (2.3%) OTH
48 3 CP-KP NDM 3 (6.8%) KBTH
101 5 CP-KP NDM 5 (11.4%) All except SUH
119 1 CP-KP NDM 1 (2.3%) STH
219 1 CP-KP NDM 1 (2.3%) OTH
376 1 CP-KP GES 1 (2.3%) SUH
383 8 CP-KP 2-NDM, 1-GES, 3-OXA-48, 1-NDM+GES, 1-OXA-48+GES 8 (18.2%) All except KBTH
437 1 CP-KP NDM 1 (2.3%) RNH
462 OXA-48 1 (2.3%) RNH
524 NDM 1 (2.3%) SUH
589 NDM 1 (2.3%) RNH
649 3 CP-KP 2-NDM, 1-OXA-48 3 (6.8%) OTH, RNH
654 OXA-48 1(2.3%) OTH
657 NDM 1 (2.3%) OTH
677 NDM 1 (2.3%) RNH
846 2 CP-KP NDM 2 (4.5%) RNH
1029 OXA-48 1 (2.3%) SUH
1289 GES 1 (2.3%) OTH
1806 NDM+VIM 1 (2.3%) OTH
2260 NDM 1 (2.3%) OTH
2461 OXA-48+GES 1 (2.3%) SUH
2674 NDM+VIM 1 (2.3%) RNH
2695 NDM 1 (2.3%) SUH
2870 NDM 1 (2.3%) OTH
2923 NDM 1 (2.3%) RNH
3229 2 CP-KP NDM 2 (4.5%) KBTH
3467 NDM+OXA-48+ VIM 1 (2.3%) SUH
ig. 1. Maximum likelihood phylogeny (PhyML) of concatenated STs identified in the study. The STs fall into four major clusters that are heterogeneous with multiple STs from
ifferent hospitals, indicating unique diverse STs to each hospital, but intra-hospital circulating clones. The largest heterogeneity is observed in cluster 4, which appears to
ave three sub-clusters. Two singletons: ST48 and ST2923 are also identified that do not fall within the clusters. Resistance genes are spread across different STs and clusters
also detailed in Table 3).bserved in SUH and RNH (Fig. 1), where it is apparent that
ultiple lineages are present simultaneously in the hospital. OTH,
n the other hand, has the least diversity and appears to have one
ajor CP-KP clone of closely related STs (645, 1289, 657, 2870, 219,
nd 2260) in addition to other sporadic STs. The diversity observed
n this study may also represent isolates brought to the hospitals24our study we did not detect the KPC gene, and the global ST258 was
not identified [4].
In conclusion, our study provides an overview of the molecular
epidemiology of K. pneumoniae in Khartoum thereby collecting
samples from four hospitals representing the three regions,
revealing a heterogeneous population of MDR K. pneumoniae4
E.A. Osman, N.E. El-Amin, L.L. Al-Hassan et al. Journal of Global Antimicrobial Resistance 24 (2021) 241–245isolates and the presence of four major clusters highlighting a large
inter-hospital spread of diverse clones in Khartoum, Sudan. The
data highlighted an alarming rate of 40% carbapenem resistance.
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